Induction of second trimester abortion with mifepristone and gemeprost.
OBJECTIVE
To determine the efficacy of a new regimen of the antiprogestogen mifepristone and gemeprost for midtrimester abortion.


METHODS
Prospective study.


METHODS
Medical Termination Unit, Simpson Memorial Maternity Pavilion, Edinburgh.


METHODS
One hundred women undergoing midtrimester abortion.


METHODS
Women were pretreated with 200 mg mifepristone 36 h before prostaglandin; 1 mg gemeprost was administered every 6 h for the first 24 h. If abortion had not occurred, 1 mg gemeprost was administered 3 hourly over the next 12 h.


RESULTS
Ninety-six percent and 99% women aborted within 24 h and 48 h, respectively. The median prostaglandin-abortion interval was significantly shorter in multigravidae compared to primigravida (6.6 vs 8.2 h, P < 0.01). The median number of gemeprost pessaries to induce abortion was only two and 47% of women required one pessary. The incidence of vomiting and diarrhoea was 31% and 5%, respectively. Eighty-four percent of women required intramuscular diamorphine for analgesia. Thirty-three percent of women required an evacuation of the uterus following abortion.


CONCLUSIONS
The shortened induction-delivery interval following pretreatment with mifepristone makes it possible to conduct midtrimester abortion on a daycare basis.
Department of Obstetrics and Gynaecology, University of Edinburgh.
K J
KJ
Thong
D T
DT
Baird
D000020:Abortifacient Agents, Nonsteroidal / Q000009:adverse effects; D000028:Abortion, Induced; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000527:Alprostadil / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D015735:Mifepristone; D010570:Pessaries; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011446:Prospective Studies; D013997:Time Factors; D016896:Treatment Outcome
D000020:Abortifacient Agents, Nonsteroidal; D015735:Mifepristone; C021182:gemeprost; D000527:Alprostadil